ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!Medpace Holdings, Inc. (MEDP) stock declined over -3.42%, trading at $325.87 on NASDAQ, down from the previous close of $337.41. The stock opened at $338.22, fluctuating between $324.98 and $339.93 in the recent session.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Employees | 5900 |
Beta | 1.47 |
Sales or Revenue | $1.89B |
5Y Sales Change% | 2.097% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Diagnostics & Research |
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com